Records containing: Type 2 Diabetes Mellitus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-03Effect of a Structured Clinical and Pharmacological Management Strategy on Cardiovascular Risk Factors in Adult Patients in Routine Clinical Practice: A Pseudo-Experimental Before-and-After Study
-
CLINICAL_TRIALS study record update · 2026-02-25Multicenter Observational Study POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes in Real-world Clinical Practice.
-
CLINICAL_TRIALS study record update · 2026-02-23Effectiveness and Implementation of an AI-Driven Blended Care Model for Type 2 Diabetes Management in Primary Care: A Single-Blind, Cluster Randomized Controlled Trial in Zhangjiagang, China
-
CLINICAL_TRIALS study record update · 2026-02-20A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (DECIDE Study)
-
CLINICAL_TRIALS study record update · 2026-02-19Metabolic, Inflammatory, Cognitive Risk Stratification, and Intensive Aerobic and Resistance Exercise Intervention for Middle-aged and Older Adults With Type 2 Diabetes Mellitus
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-11GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
-
CLINICAL_TRIALS study record update · 2026-02-06Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
-
CLINICAL_TRIALS study record update · 2026-02-05A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Center Study to Evaluate the Efficacy, Safety, and Tolerability of CT-868 Administered for 26 Weeks to Overweight and Obese Participants With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2026-02-04Disaster Preparedness in Patients With Diabetic Foot: The Effect of an Educational Intervention
-
CLINICAL_TRIALS study record update · 2026-01-30Feasibility of Simplified Onboarding in Adults With Type 2 Diabetes Using Automated Insulin Delivery
-
CLINICAL_TRIALS study record update · 2026-01-29Carotid Wall Layer Texture as a Potential Biomarker for Cardiovascular Risk Assessment in Preventive Nursing: a Study in Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2026-01-28Efficacy and Safety of Cagrilintide s.c. 2.4 mg in Combination With Semaglutide s.c. 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly in Participants With Overweight or Obesity and Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2026-01-26Laparoscopic Sleeve Gastrectomy Versus Conventional Medical Therapy in Patients With Newly Diagnosed Type 2 Diabetes and Body Mass Index 30-42 Kg/m2: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-01-22Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. in Doses 2.4/2.4 mg and 1.0/1.0 mg Once Weekly Versus Semaglutide 2.4 mg and 1.0 mg, Cagrilintide 2.4 mg and Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Metformin With or Without an SGLT2 Inhibitor
-
CLINICAL_TRIALS study record update · 2026-01-20A Phase 2 Randomized, Placebo-controlled, Double-blind, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2026-01-20A Randomized, Placebo-Controlled, Parallel Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
-
CLINICAL_TRIALS study record update · 2026-01-16A Phase 1, Randomized, Parallel Assignment, Double Blind, Placebo Controlled, Single and Multiple Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of ZT002 in Healthy Participants
-
CLINICAL_TRIALS study record update · 2026-01-14The Effect of Effort During a Resistance Exercise Session on Glycemic Control in Individuals With Prediabetes or Type 2 Diabetes Mellitus: a Randomized-controlled Trial
-
CLINICAL_TRIALS study record update · 2026-01-12IMPROVE-T2D Study: Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2026-01-06Effects of Liraglutide, Empagliflozin and Linagliptin on Mild Cognitive Impairment Remission in Type 2 Diabetes (LIGHT-MCI): A Multicentre, Randomised Controlled Trial With An Extension Phase
-
CLINICAL_TRIALS study record update · 2025-12-29Generative AI Simulation for Diagnostic Communication in Type 2 Diabetes: A Randomized Controlled Trial (DIALOGUE-DM2)
-
CLINICAL_TRIALS study record update · 2025-12-23The Effect of Turtle Therapy on HbA1c and Self-Efficacy Levels in Diabetes Medication Use in Individuals With Type 2 Diabetes: A Double-Blind Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2025-12-23Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism
-
CLINICAL_TRIALS study record update · 2025-12-22Exploration of the Lipid Metabolism During the Diabetic Pregnancies and Research for New Biological Predictors to Nutritional Interventions
-
CLINICAL_TRIALS study record update · 2025-12-15Functional Deconstruction of Human Milk Oligosaccharides and Lipids